Bloomberg file photo
The U.S. subsidiaries of French pharmaceutical giant Sanofi will pay $109 million to settle allegations they gave kickbacks to induce doctors to buy and prescribe Hyalgan, a knee injection.
The Justice Department alleges that Sanofi-Aventis U.S. Inc. and Sanofi-Aventis U.S. LLC violated the False Claims Act by giving doctors thousands of free units of Hyalgan as the drug faced pressure from a lower-priced competitor.
The agency also alleges Sanofi submitted false reports on the average sale price of Hyalgan that excluded the free units, causing Medicare and other federal health care programs to reimburse the company at inflated rates.
In a statement, Sanofi US said it cooperated fully with the government review and "existing financial reserves" will cover the settlement. The company said it voluntarily stopped sampling Hyalgan in 2009.
Associated Press
RECOMMENDED • nj .com
Tito Jackson, member of the Jackson 5, has died at 70, his sons say Sep. 16, 2024, 1:49 a.m.
If you purchase a product or register for an account through a link on our site, we may receive compensation. By using this site, you consent to our User Agreement and agree that your clicks, interactions, and personal information may be collected, recorded, and/or stored by us and social media and other third-party partners in accordance with our Privacy Policy.
Cookie Settings
Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement, (updated 8/1/2024) and acknowledgement of our Privacy Policy, and Your Privacy Choices and Rights (updated 7/1/2024).
© 2024 Advance Local Media LLC. All rights reserved (About Us).
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Advance Local.
Community Rules apply to all content you upload or otherwise submit to this site.
YouTube's privacy policy is available here and YouTube's terms of service is available here.